<p>I<sub>X</sub> indicates timing of assessments. One participant withdrew from the study during stage 1 due to injury, while the two subjects that withdrew after crossover were either lost to follow up or to the developing acne.</p
<p>ITT: intention-to-treat. One subject in the dietary supplement group was lost to follow-up at Mon...
OBJECTIVES: The objective of the study was to identify the reasons for discontinuation of clinical d...
<p>74 volunteers were screened. 2 subjects did not fulfil recruitment criteria and were excluded. A ...
<p>Summary of study’s recruitment process and trial execution. I<sub>X</sub> indicates timing of ass...
<p>“Withdrawn” indicates participants’ withdrawal from trial and all associated research activities....
Subject participation is crucial to drug development studies. Numbers of subjects are greatly reduce...
<p>CONSORT flow diagram showing subject recruitment and follow up. Subjects were allocated to Groups...
<p><sup>1</sup>Only data that accrued until the study participant was prematurely withdrawn from the...
<p>In Analysis 1, patients were followed for 365 days for the outcomes of interest. In Analysis 2, a...
<p>Eighteen subjects were screened for eligibility to participate in the trial and 7 healthy volunte...
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
<p>Study participants were split into two groups, those who returned to the convalescent visit (left...
<p>Progression of participants in the trial, including those who met the exclusion criteria, those w...
Maintaining good compliance is a major challenge in long-term cancer chemoprevention trials. Minimiz...
<p>* The patient who was lost to follow-up at 3 months was excluded from the analysis of the 3 month...
<p>ITT: intention-to-treat. One subject in the dietary supplement group was lost to follow-up at Mon...
OBJECTIVES: The objective of the study was to identify the reasons for discontinuation of clinical d...
<p>74 volunteers were screened. 2 subjects did not fulfil recruitment criteria and were excluded. A ...
<p>Summary of study’s recruitment process and trial execution. I<sub>X</sub> indicates timing of ass...
<p>“Withdrawn” indicates participants’ withdrawal from trial and all associated research activities....
Subject participation is crucial to drug development studies. Numbers of subjects are greatly reduce...
<p>CONSORT flow diagram showing subject recruitment and follow up. Subjects were allocated to Groups...
<p><sup>1</sup>Only data that accrued until the study participant was prematurely withdrawn from the...
<p>In Analysis 1, patients were followed for 365 days for the outcomes of interest. In Analysis 2, a...
<p>Eighteen subjects were screened for eligibility to participate in the trial and 7 healthy volunte...
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
<p>Study participants were split into two groups, those who returned to the convalescent visit (left...
<p>Progression of participants in the trial, including those who met the exclusion criteria, those w...
Maintaining good compliance is a major challenge in long-term cancer chemoprevention trials. Minimiz...
<p>* The patient who was lost to follow-up at 3 months was excluded from the analysis of the 3 month...
<p>ITT: intention-to-treat. One subject in the dietary supplement group was lost to follow-up at Mon...
OBJECTIVES: The objective of the study was to identify the reasons for discontinuation of clinical d...
<p>74 volunteers were screened. 2 subjects did not fulfil recruitment criteria and were excluded. A ...